December 1 - 6, 2024
Boston, Massachusetts
Symposium Supporters
2024 MRS Fall Meeting & Exhibit
NM06.02.03

Acidification-Induced Structural Evolution Within Ionizable Lipid Nanoparticles Correlates with mRNA Transfection in Macrophages

When and Where

Dec 2, 2024
2:15pm - 2:30pm
Hynes, Level 1, Room 103

Presenter(s)

Co-Author(s)

Haitao Yu1,Joshua Iscaro1,Brendan Dyett1,Calum Drummond1,Steven Bozinovski1,Jiali Zhai1

RMIT University1

Abstract

Haitao Yu1,Joshua Iscaro1,Brendan Dyett1,Calum Drummond1,Steven Bozinovski1,Jiali Zhai1

RMIT University1
Lipid nanoparticles (LNPs) represent a revolutionary technology for mRNA delivery, offering potential in preventing and treating various diseases, including those addressed by the COVID-19 vaccines. Our recent research involves the development and characterization of LNP formulations using ionizable amino-lipids, including ALC-0315 and SM-102 from COVID-19 vaccines, along with innovative structure-forming helper lipids like monoolein and phytantriol. Using high-throughput small-angle X-ray scattering (SAXS) in Australian Synchrotron, we observed acidification-induced structural transitions in these ionizable LNPs from inverse micellar to hexagonal and cubic phases, within a pH range of 7 to 4, mimicking the endosomal environment. These transitions significantly enhanced the transfection efficiency in macrophages, with SM-102-based LNPs performing better due to their ability to form cubic structures at lower pH conditions.<br/><br/>Additionally, we explored how the components, such as cholesterol, stabilizers, and mRNA cargos, modulate these phase transitions and mRNA transfection. Notably, the cholesterol-enriched formulations contributed to nanostructure transitions and protein corona variations, enhancing transfection efficiency in both immortalized alveolar and primary macrophage cell lines. Our <i>ex vivo</i> studies confirmed the capacity of these LNPs in reprogramming macrophages, highlighting their potential for cell-based therapies in lung diseases.<br/><br/>Our findings elucidate the connection between LNP structural evolution and mRNA transfection efficiency, providing valuable insights for the design of next-generation LNP systems for therapeutic applications. This research underscores the importance of mesophase behavior in optimizing LNP formulations for targeted gene delivery and advancing the field of mRNA therapeutics.<br/><br/>References<br/>1. <u>Yu, H.</u><sup>1</sup>; Iscaro, J.<sup>1</sup>; Dyett, B.<sup>1</sup>; Zhang, Y.; Seibt, S.; Martinez, N.; White, J.; Drummond, C. J.; Bozinovski, S.; Zhai, J. Inverse Cubic and Hexagonal Mesophase Evolution within Ionizable Lipid Nanoparticles Correlates with MRNA Transfection in Macrophages. <i>J. Am. Chem. Soc.</i> <b>2023</b>, <i>145</i> (45), 24765–24774. (SI cover)<br/>2. <u>Yu, H.</u>; Angelova, A.; Angelov, B.; Dyett, B.; Matthews, L.; Zhang, Y.; El Mohamad, M.; Cai, X.; Valimehr, S.; Drummond, C. J.; Zhai, J. Real–Time PH–Dependent Self–Assembly of Ionisable Lipids from COVID–19 Vaccines and In Situ Nucleic Acid Complexation. <i>Angew. Chemie</i> <b>2023</b>, <i>135</i> (35), e202304977.<br/>3. <u>Yu, H.</u><sup>1</sup>; Dyett, B.<sup>1</sup>; Kirby, N.; Cai, X.; Mohamad, M. El; Bozinovski, S.; Drummond, C. J.; Zhai, J. PH–Dependent Lyotropic Liquid Crystalline Mesophase and Ionization Behavior of Phytantriol-Based Ionizable Lipid Nanoparticles. <i>Small</i> <b>2024</b>, <i>2309200</i>, 1–10. (Front cover)<br/>4. Iscaro, J.<sup>1</sup>; <u>Yu, H.</u><sup>1</sup>; Martinez, N.; Subramaniam, S.; Joyce, P.; Wang H.; Dyett, B.; White, J.; Prestidge, C., Drummond, C. J.; Bozinovski, S.; Zhai, J. Lyotropic Liquid Crystalline Phase Nanostructure and Cholesterol Enhance Lipid Nanoparticle Mediated mRNA Transfection in Macrophages. <i>Adv. Funct. Mater.</i> <b>2024</b>, Accepted.

Keywords

nanostructure

Symposium Organizers

Alon Gorodetsky, University of California, Irvine
Marc Knecht, Univ of Miami
Tiffany Walsh, Deakin University
Yaroslava Yingling, North Carolina State University

Session Chairs

Marc Knecht
Yaroslava Yingling

In this Session